{"domain":"angiosafe.com","status":"valid","tier":"listed","authority":46,"verified":false,"title":"AngioSafe","summary":"AngioSafe, Inc. is a medical device manufacturer specializing in peripheral vascular intervention. Its primary product is the Santreva-ATK Endovascular Revascularization Catheter, an Atheroplasty-platform device intended to facilitate intraluminal guidewire placement across stenotic lesions, including Chronic Total Occlusions (CTOs), in the femoropopliteal peripheral vasculature. FDA 510(k) cleared (U.S.) and CE marked (EU).","country":"US","country_source":"ip","publisher_country":null,"publisher_country_source":null,"hosting_country":"US","llms_txt":"https://www.angiosafe.com/llms.txt","llms_full_txt":null,"last_checked":"2026-10-24T23:54:01.322Z","agent_terms":null,"categories":["industrial-manufacturing","healthcare"],"capabilities":[],"inferred_tags":["peripheral vascular intervention","atheroplasty","santreva-atk catheter","medical device","fda 510k"],"audience":"mixed","agent_uses":["read_docs","search_content"],"language":"en","platform_generated":false,"agent_summary":"AngioSafe medical device maker; Santreva-ATK endovascular catheter for femoropopliteal CTO crossing, FDA 510(k) cleared and CE marked. Includes IFU and clinical","llms_txt_cached":"https://agentwebmap.com/v1/domain/angiosafe.com/llms.txt","agentic":"documentation","section_keys":["citation-guidance","clinical-evidence","disallowed-uses","indications-and-intended-use","optional","preferred-ai-summary-order","priority-pages","safety-and-fair-balance"],"section_partial":false,"section_indexed_at":"2026-10-24T23:54:08.661Z"}